Suchergebnisse - "Guerrero Patiño, Diana"

PubPharm (24)

1

Cost effectiveness of omalizumab for severe asthma in Colombia

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2024

von Buendía, J. | Guerrero Patiño, D. | Zuluaga Salazar, A.

2

Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2024

von Buendia, J. | Guerrero-Patino, D. | Zuluaga, A.

3

Economic evidence supports the cost savings of sputum eosinophil counts to guide the treatment of pediatrics patients with persistent asthma : implications for clinical practice guidelines in middle-income countries

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2023

von Buendía, J. | Guerrero Patiño, D. | Zuluaga Salazar, A.

4

Phosphodiesterase 5 Inhibitor for Pediatric Pulmonary Arterial Hypertension : A Cost-Utility Analysis

enthalten in: Value in health regional issues | 2023

von Buendía, J. | Lindarte, E. | Guerrero Patiño, D.

5

Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma

enthalten in: The Journal of asthma : official journal of the Association for the Care of Asthma | 2022

von Buendia, J. | Guerrero Patiño, D. | Cossio-Giraldo, Y.

6

Vitamin A supplementation for the prevention of chronic lung disease in premature infants : A cost-utility analysis

enthalten in: Pediatric pulmonology | 2022

von Buendía, J. | Guerrero Patiño, D. | Lindarte, E.

7

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma : a cost-utility analysis

enthalten in: BMC pulmonary medicine | 2022

von Buendía, J. | Guerrero Patiño, D. | Sánchez Caraballo, J.

8

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis

enthalten in: BMC pulmonary medicine | 2022

von Buendía, J. | Guerrero Patiño, D. | Sánchez Caraballo, J.

9

Fractional exhaled nitric oxide and eosinophil count in induced sputum to guide the management of children with asthma: a cost-utility analysis

enthalten in: BMC pulmonary medicine | 2022

von Buendía, J. | Guerrero Patiño, D. | Sánchez Caraballo, J.

10

Podotimod in pediatric recurrent respiratory tract infections : a cost-utility analysis

enthalten in: BMC pulmonary medicine | 2022

von Buendía, J. | Guerrero Patiño, D. | Lindarte, E.